VanEck Pharmaceutical ETF (PPH) News Today → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free PPH Stock Alerts $88.88 -0.99 (-1.10%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | msn.comJust Say No to Drugs: 3 Pharma Stocks to AvoidApril 23, 2024 | seekingalpha.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 18, 2024 | theglobeandmail.comCanada’s updated guidance on ESG-related investment fund disclosureApril 3, 2024 | msn.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328March 7, 2024 | investorplace.comThe Top 3 ETFs to Buy in March 2024February 28, 2024 | markets.businessinsider.com11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsFebruary 28, 2024 | stocknews.comNavigate to Success With These 4 Pharma Stocks to BuyFebruary 26, 2024 | investorplace.comThe 3 Hottest Healthcare ETFs to Buy in 2024February 21, 2024 | seekingalpha.comPPH VanEck Pharmaceutical ETFFebruary 20, 2024 | msn.comHealthcare dealmakers see increased M&A, valuations in 2024: KPMGJanuary 28, 2024 | msn.comBig Pharma earnings season in spotlight amid positive sentimentJanuary 8, 2024 | finance.yahoo.com5 ETF Zones Scaling New Highs at the Start of 2024December 29, 2023 | msn.comPfizer in 2024: What to expect?December 28, 2023 | msn.comGilead in 2024: What to expect?December 27, 2023 | marketbeat.comVanEck Pharmaceutical ETF Announces Dividend of $0.31 (NASDAQ:PPH)VanEck Pharmaceutical ETF (NASDAQ:PPH) announced a dividend on Tuesday, December 26th. Investors of record on Thursday, December 28th will be given a dividend of 0.3074 per share on Friday, December 29th. The ex-dividend date is Wednesday, December 27th.December 26, 2023 | marketbeat.comVontobel Holding Ltd. Has $799,000 Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Vontobel Holding Ltd. trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 78.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,000 shares of the company's stock after selling 36,000 sDecember 6, 2023 | cnbc.comETFs to buy and sell as the GLP-1 craze boomsNovember 14, 2023 | uk.finance.yahoo.com10 Best Performing Healthcare ETFs in 2023November 6, 2023 | msn.comPharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your PortfolioNovember 1, 2023 | investing.comPPH ETF Stock Price HistoryOctober 29, 2023 | msn.comPPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling PortfolioOctober 26, 2023 | stocknews.com3 Resilient Pharma Stocks to Buy This WeekOctober 25, 2023 | msn.comOzempic craze drives big flows into pharmaceutical, Danish fundsOctober 19, 2023 | seekingalpha.comEli Lilly, Novo among notable decliners in pharma weaknessSeptember 15, 2023 | stocknews.comWhich of these 3 Pharma Stocks Should You Buy, Hold or Sell?September 4, 2023 | marketbeat.comHRT Financial LP Increases Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)HRT Financial LP grew its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 1,225.5% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 67,098 shares of the company's stock after buying an additional 62,036 shares during the period. HRT FinaSeptember 3, 2023 | msn.comWhy is big pharma unmoved despite Medicare pricing threat?August 28, 2023 | marketbeat.comShort Interest in VanEck Pharmaceutical ETF (NASDAQ:PPH) Drops By 17.0%VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 2,000,000 shares, a decrease of 17.0% from the July 31st total of 2,410,000 shares. Based on an average daily volume of 127,800 shares, the short-interest ratio is presently 15.6 days.August 11, 2023 | au.news.yahoo.comPharma ETF (PPH) Hit a 52-Week HighJuly 27, 2023 | marketbeat.comRaymond James & Associates Cuts Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James & Associates trimmed its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 77.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,706 shares of the company's stock after selling 23,3July 24, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Trims Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James Financial Services Advisors Inc. trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) by 87.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,762 shares of the compaJuly 6, 2023 | finance.yahoo.comPPH - VanEck Pharmaceutical ETFJuly 4, 2023 | marketbeat.comInternational Assets Investment Management LLC Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)International Assets Investment Management LLC acquired a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 1,708 shares of the company's stock, valued atJune 29, 2023 | msn.comSanofi: EPS Momentum Driven By Dupixent, Vaccines Day On TapJune 26, 2023 | marketbeat.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Vontobel Holding Ltd.Vontobel Holding Ltd. lifted its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 78.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,000 shares of the company's stock after buying an additional 1June 21, 2023 | msn.comETFs to Capitalize on Eli Lilly's Buyout of DICE TherapeuticsJune 13, 2023 | marketbeat.comAlerus Financial NA Invests $3.69 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH)Alerus Financial NA purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,420 shares of the company's stock, valuedJune 6, 2023 | marketbeat.comHRT Financial LP Sells 40,941 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)HRT Financial LP trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 89.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 5,062 shares of the company's stock after selling 40,941 shares during the quarter. HRT FinanJune 2, 2023 | marketbeat.com2,923 Shares in VanEck Pharmaceutical ETF (NASDAQ:PPH) Purchased by Miller Investment Management LPMiller Investment Management LP acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,923 shaMay 29, 2023 | marketbeat.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Stock Holdings Lessened by Phoenix Holdings Ltd.Phoenix Holdings Ltd. lowered its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 0.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,195,008 shares of the company's stock afMay 26, 2023 | fool.comVanEck ETF Trust - VanEck Pharmaceutical ETF (NASDAQ: PPH)May 26, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Increases Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)Raymond James Financial Services Advisors Inc. increased its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 586.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,364 shares of the company's stock afterMay 19, 2023 | marketbeat.comCommonwealth Equity Services LLC Acquires 4,688 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)Commonwealth Equity Services LLC boosted its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 29.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,737 shares of the company's stock after acquirMay 16, 2023 | marketbeat.comVanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by UBS Group AGUBS Group AG decreased its position in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 19.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 412,429 shares of the company's stock after selling 97,34May 13, 2023 | nasdaq.comHow the Pharmaceutical Industry Is Using AIMay 12, 2023 | marketbeat.comLPL Financial LLC Grows Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)LPL Financial LLC raised its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 52.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,555 shares of the company's stock after purchasing an additioMay 8, 2023 | marketbeat.comOrion Portfolio Solutions LLC Trims Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)Orion Portfolio Solutions LLC lowered its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 3.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,940 shares of the companyMay 2, 2023 | marketbeat.comBank of Montreal Can Reduces Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH)Bank of Montreal Can lowered its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 20.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 7,502 shares of the company's stock after selling 1,942 shares during the quarter. Bank of MoApril 28, 2023 | marketbeat.comLansing Street Advisors Sells 5,923 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)Lansing Street Advisors trimmed its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH - Get Rating) by 18.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,310 shares of the company's stock after selling 5,923 shares Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. PPH Media Mentions By Week PPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPH News Sentiment▼1.591.26▲Average Manufacturing News Sentiment PPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPH Articles This Week▼30▲PPH Articles Average Week Get VanEck Pharmaceutical ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BBH News PSCH News BIB News BTEC News IBBQ News IBB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PPH) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
